{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:28:31Z","timestamp":1791462511515,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011104","name":"Universitat Aut\u00f2noma de Barcelona","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011104","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Differential diagnosis in children presenting with dilated cardiomyopathy and severe cardiac dysfunction is challenging. In our hospital, a protocol was established in 2015 in which endomyocardial biopsy (EMB) was performed in selected patients and treatment was guided by biopsy results. The study aims to describe our experience with this diagnostic and therapeutic strategy.\u00a0We performed a unicenter paediatric ambispective study that include patients with dilated cardiomyopathy and severe cardiac dysfunction (left ventricular ejection fraction (LVEF)\u2009&lt;\u200935%) in whom EMB was performed and treatment was prescribed based on EMB results from February 2015 to December 2024.\u00a023 patients (24 episodes) were included. 15 patients had a complete recovery, 5 patients had a partial response to treatment and 4 had no response to treatment. Patients were divided into two groups, those with complete recovery (15) and those without complete recovery (9). No differences were observed in sex, age, clinical presentation, need for Extracorporeal Membrane Oxygenation (ECMO) or echocardiogram parameters. Complete recovery was associated with a higher degree of inflammation on EMB (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), necrosis (=\u20090.007) and oedema (<jats:italic>p<\/jats:italic>\u2009=\u20090.036), negative genetic testing (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), higher troponin values (<jats:italic>p<\/jats:italic>\u2009=\u20090.015) and positive viral PCR in myocardial tissue (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001).  <jats:italic>Conclusion<\/jats:italic>: EMB is a valuable tool for diagnosis and treatment of paediatric patients presenting with dilated cardiomyopathy. Factors associated with a favourable response to therapy include: intense inflammatory infiltrate in EMB, oedema, necrosis, positive viral PCR found in the myocardium, high elevation of troponins and negative genetic testing.\n<jats:table-wrap>\n              <jats:table>\n                <jats:tbody>\n                  <jats:tr>\n                    <jats:td align=\"left\">\n                      <jats:bold>What is Known:<\/jats:bold>\n                    <\/jats:td>\n                  <\/jats:tr>\n                  <jats:tr>\n                    <jats:td align=\"left\">\u2022 <jats:italic>Differential diagnosis in paediatric patients presenting with severe dysfunction is challenging<\/jats:italic>\u2022 <jats:italic>EMB remains the gold standard technique for the diagnosis of myocarditis and can help to guide treatment<\/jats:italic>\n                    <\/jats:td>\n                  <\/jats:tr>\n                  <jats:tr>\n                    <jats:td align=\"left\">\n                      <jats:bold>What is New:<\/jats:bold>\n                    <\/jats:td>\n                  <\/jats:tr>\n                  <jats:tr>\n                    <jats:td align=\"left\">\u2022 <jats:italic>EMB guided treatment my benefit paediatric patients with inflammatory cardiomyopathy<\/jats:italic>.\u2022 <jats:italic>Factors associated with a favourable response to treatment in patients presenting with severe cardiac dysfunction include: intense inflammatory infiltrate in EMB, oedema, necrosis, positive viral PCR in the myocardium, high elevation of troponins and negative genetic testing<\/jats:italic>.\u2022 <jats:italic>Positive genetic testing was observed in some patients with inflammatory cardiomyopathy. In our opinion, genetic testing should be considered in all patients presenting with severe dysfunction<\/jats:italic>.\u2022 <jats:italic>Interferon \u03b2 combined with corticosteroids may offer a beneficial treatment approach in patients with Parvovirus B19-induced myocarditis<\/jats:italic>\n                    <\/jats:td>\n                  <\/jats:tr>\n                <\/jats:tbody>\n              <\/jats:table>\n            <\/jats:table-wrap>\n          <\/jats:p>","DOI":"10.1007\/s00431-025-06424-x","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T04:28:48Z","timestamp":1758169728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Histological guided treatment in paediatric patients presenting with severe left ventricular dysfunction"],"prefix":"10.1007","volume":"184","author":[{"given":"Paola","family":"Dolader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Carolina","family":"Juzga Corrales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Esmel-Vilomara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Daina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Izquierdo-Blasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Garrido-Pontnou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Fidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"S\u00e1nchez-Salmador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuensanta","family":"Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mois\u00e9s","family":"Sorli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Betrian-Blasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Roses-Noguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Gran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"6424_CR1","doi-asserted-by":"publisher","unstructured":"Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, Bezzina CR, Biagini E, Blom NA, de Boer RA, De Winter T, Elliott PM, Flather M, Garcia-Pavia P, Haugaa KH, Ingles J, Jurcut RO, Klaassen S, Limongelli G, Loeys B, Mogensen J, Olivotto I, Pantazis A, Sharma S, Van Tintelen JP, Ware JS, Kaski JP (2023) ESC Scientific Document Group. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 44(37):3503-3626. https:\/\/doi.org\/10.1093\/eurheartj\/ehad194. PMID: 37622657","DOI":"10.1093\/eurheartj\/ehad194"},{"issue":"1","key":"6424_CR2","doi-asserted-by":"publisher","first-page":"e21726","DOI":"10.7759\/cureus.21726","volume":"14","author":"S Keramari","year":"2022","unstructured":"Keramari S, Poutoglidis A, Chatzis S, Keramaris M, Savopoulos C, Kaiafa G (2022) Parvovirus B19-Associated Myocarditis: A Literature Review of Pediatric Cases. Cureus 14(1):e21726. https:\/\/doi.org\/10.7759\/cureus.21726","journal-title":"Cureus"},{"key":"6424_CR3","doi-asserted-by":"publisher","unstructured":"Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, Friedrich MG, Klingel K, Lehtonen J, Moslehi JJ, Pedrotti P, Rimoldi OE, Schultheiss HP, Tsch\u00f6pe C, Cooper LT Jr, Camici PG (2020) Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document. Circ Heart Fail 13(11):e007405. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.120.007405. Epub 2020 Nov 12. PMID: 33176455; PMCID: PMC7673642","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405"},{"key":"6424_CR4","doi-asserted-by":"publisher","unstructured":"Alida L P Caforio , Sabine Pankuweit, Eloisa Arbustini, Cristina Basso, Juan Gimeno-Blanes, Stephan B Felix, Michael Fu, Tiina Heli\u00f6, Stephane Heymans, Roland Jahns, Karin Klingel, Ales Linhart, Bernhard Maisch, William McKenna, Jens Mogensen, Yigal M Pinto, Arsen Ristic, Heinz-Peter Schultheiss, Hubert Seggewiss, Luigi Tavazzi, Gaetano Thiene, Ali Yilmaz, Philippe Charron, Perry M Elliott (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34(33):2636\u201348, 2648a-2648d. PMID: 23824828. https:\/\/doi.org\/10.1093\/eurheartj\/eht210","DOI":"10.1093\/eurheartj\/eht210"},{"issue":"6","key":"6424_CR5","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.jchf.2024.02.012","volume":"12","author":"E Monda","year":"2024","unstructured":"Monda E, Bakalakos A, Cannie D, O\u2019Mahony C, Syrris P, Kaski JP, Limongelli G, Elliott PM (2024) Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Acute Myocarditis: A Systematic Review and Meta-Analysis. JACC Heart Fail 12(6):1101\u20131111. https:\/\/doi.org\/10.1016\/j.jchf.2024.02.012. (Epub 2024 Apr 3 PMID: 38573261)","journal-title":"JACC Heart Fail"},{"key":"6424_CR6","doi-asserted-by":"publisher","unstructured":"Seidel F, Holtgrewe M, Al-Wakeel-Marquard N, Opgen-Rhein B, Dartsch J, Herbst C, Beule D, Pickardt T, Klingel K, Messroghli D, Berger F, Schubert S, K\u00fchnisch J, Klaassen S (2021) Pathogenic Variants Associated With Dilated Cardiomyopathy Predict Outcome in Pediatric Myocarditis. Circ Genom Precis MeD 14(4):e003250. https:\/\/doi.org\/10.1161\/CIRCGEN.120.003250. Epub 2021 Jul 2. PMID: 34213952; PMCID: PMC8373449. Final del formulario","DOI":"10.1161\/CIRCGEN.120.003250"},{"key":"6424_CR7","doi-asserted-by":"publisher","unstructured":"Asatryan B, Asimaki A, Landstrom AP, Khanji MY, Odening KE, Cooper LT, Marchlinski FE, Gelzer AR, Semsarian C, Reichlin T, Owens AT, Chahal CAA (2021) Inflammation and Immune Response in Arrhythmogenic Cardiomyopathy: State-of-the-Art Review. Circulation 144(20):1646\u20131655. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.055890. Epub 2021 Nov 15. PMID: 34780255; PMCID: PMC9034711","DOI":"10.1161\/CIRCULATIONAHA.121.055890"},{"key":"6424_CR8","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3390\/biom13040646","volume":"13","author":"G Peretto","year":"2023","unstructured":"Peretto G, Sommariva E, Di Resta C, Rabino M, Villatore A, Lazzeroni D, Sala S, Pompilio G, Cooper LT (2023) Myocardial Inflammation as a Manifestation of Genetic Cardiomyopathies: From Bedside to the Bench. Biomolecules 13:646. https:\/\/doi.org\/10.3390\/biom13040646","journal-title":"Biomolecules"},{"key":"6424_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","volume":"17","author":"L Adamo","year":"2020","unstructured":"Adamo L, Rocha-Resende C, Prabhu SD et al (2020) Reappraising the role of inflammation in heart failure. Nat Rev Cardiol 17:269\u2013285. https:\/\/doi.org\/10.1038\/s41569-019-0315-x","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"6424_CR10","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","volume":"75","author":"SP Murphy","year":"2020","unstructured":"Murphy SP, Kakkar R, McCarthy CP, Januzzi JLJ (2020) Inflammation in Heart Failure: JACC State-of-the-Art Review. J Am Coll Cardiol 75(11):1324\u20131340. https:\/\/doi.org\/10.1016\/j.jacc.2020.01.014. (PMID: 32192660)","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"6424_CR11","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1093\/eurheartj\/ehp249","volume":"30","author":"A Frustaci","year":"2009","unstructured":"Frustaci A, Russo MA, Chimenti C (2009) Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 30(16):1995\u20132002. https:\/\/doi.org\/10.1093\/eurheartj\/ehp249. (Epub 2009 Jun 25 PMID: 19556262)","journal-title":"Eur Heart J"},{"issue":"8","key":"6424_CR12","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s00059-012-3694-x","volume":"37","author":"A Frustaci","year":"2012","unstructured":"Frustaci A, Chimenti C (2012) Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy. Herz 37(8):854\u2013858. https:\/\/doi.org\/10.1007\/s00059-012-3694-x. (PMID: 23080270)","journal-title":"Herz"},{"issue":"2","key":"6424_CR13","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3390\/v14020444.PMID:35216037;PMCID:PMC8875228","volume":"14","author":"HP Schultheiss","year":"2022","unstructured":"Schultheiss HP, Bock CT, Aleshcheva G, Baumeier C, Poller W, Escher F (2022) Interferon-\u03b2 Suppresses Transcriptionally Active Parvovirus B19 Infection in Viral Cardiomyopathy: A Subgroup Analysis of the BICC-Trial. Viruses 14(2):444. https:\/\/doi.org\/10.3390\/v14020444.PMID:35216037;PMCID:PMC8875228","journal-title":"Viruses"},{"issue":"22","key":"6424_CR14","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1161\/01.CIR.0000072766.67150.51","volume":"107","author":"U K\u00fchl","year":"2003","unstructured":"K\u00fchl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, Poller W, Schultheiss HP (2003) Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107(22):2793\u20132798. https:\/\/doi.org\/10.1161\/01.CIR.0000072766.67150.51","journal-title":"Circulation"},{"issue":"14","key":"6424_CR15","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.jacc.2012.06.026","volume":"60","author":"U K\u00fchl","year":"2012","unstructured":"K\u00fchl U, Lassner D, von Schlippenbach J, Poller W, Schultheiss HP (2012) Interferon-Beta improves survival in enterovirus-associated cardiomyopathy. J Am Coll Cardiol 60(14):1295\u20131296. https:\/\/doi.org\/10.1016\/j.jacc.2012.06.026","journal-title":"J Am Coll Cardiol"},{"key":"6424_CR16","doi-asserted-by":"publisher","unstructured":"Gran F, Fidalgo A, Dolader P, Garrido M, Navarro A, Izquierdo-Blasco J, Balcells J, Codina-Sola M, Fernandez-Alvarez P, Sabat\u00e9-Rot\u00e9s A, Betri\u00e1n P, Fern\u00e1ndez-Doblas J, Abella R, Roses-Noguer F (2022) Differences between genetic dilated cardiomyopathy and myocarditis in children presenting with severe cardiac dysfunction. Eur J Pediatr 181(1):287\u2013294. https:\/\/doi.org\/10.1007\/s00431-021-04175-z. Epub 2021 Jul 20. PMID: 34286374; PMCID: PMC8294227","DOI":"10.1007\/s00431-021-04175-z"},{"key":"6424_CR17","doi-asserted-by":"publisher","unstructured":"Gran F, Dolader P, Juzga-Corrales DC, Esmel-Vilomara R, Betrian P, Escudero F, Sorli M, Melendo S, Garrido-Pontnou M, Navarro A, Camacho J, Izquierdo-Blasco J, Daina C, Escrib\u00e0 S, Fern\u00e1ndez-Polo A, Luis-Garcia M, Vera E, Martin-Talavera M (2025). Interferon-beta and corticosteroid therapy for parvovirus B19 myocarditis in children. Int J Cardiol. 133337. https:\/\/doi.org\/10.1016\/j.ijcard.2025.133337. Epub ahead of print. PMID: 40328350","DOI":"10.1016\/j.ijcard.2025.133337"},{"key":"6424_CR18","doi-asserted-by":"publisher","unstructured":"Hanson PJ, Liu-Fei F, Minato TA, Hossain AR, Rai H, Chen VA, Ng C, Ask K, Hirota JA, McManus BM (2022) Advanced detection strategies for cardiotropic virus infection in a cohort study of heart failure patients. Lab Invest 102(1):14\u201324. https:\/\/doi.org\/10.1038\/s41374-021-00669-4. Epub 2021 Oct 4. PMID: 34608239; PMCID: PMC8488924","DOI":"10.1038\/s41374-021-00669-4"},{"issue":"5","key":"6424_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, Laboratory Quality Assurance Committee ACMG (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in medicine: official journal of the American College of Medical Genetics 17(5):405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genetics in medicine: official journal of the American College of Medical Genetics"},{"key":"6424_CR20","doi-asserted-by":"publisher","unstructured":"Mesquita T, Lin YN, Ibrahim A (2021) Chronic low-grade inflammation in heart failure with preserved ejection fraction. Aging Cell 20(9):e13453. https:\/\/doi.org\/10.1111\/acel.13453. Epub 2021 Aug 12. PMID: 34382743; PMCID: PMC8441359","DOI":"10.1111\/acel.13453"},{"issue":"6","key":"6424_CR21","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1161\/01.cir.0000048147.15962.31","volume":"107","author":"A Frustaci","year":"2003","unstructured":"Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A (2003) Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 107(6):857\u2013863. https:\/\/doi.org\/10.1161\/01.cir.0000048147.15962.31. (PMID: 12591756)","journal-title":"Circulation"},{"issue":"1","key":"6424_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1161\/CIRCHEARTFAILURE.110.958249","volume":"4","author":"Garrick C Stewart","year":"2011","unstructured":"Stewart Garrick C, Lopez-Molina Javier, Gottumukkala Raju V, Rosner Gregg F, Anello Mary S, Hecht Jonathan L, Winters Gayle L, Padera Robert F, Baughman Kenneth L, Lipes Myra A (2011) Myocardial Parvovirus B19 Persistence: Lack of Association with Clinicopathologic Phenotype in Adults with Heart Failure. Circ Heart Fail 4(1):71\u201378. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.110.958249","journal-title":"Circ Heart Fail"},{"key":"6424_CR23","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/ejhf.665","volume":"18","author":"J Verdonschot","year":"2016","unstructured":"Verdonschot J, Hazebroek M, Merken J, Debing Y, Dennert R, Brunner-La Rocca H-P, Heymans S (2016) Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature. Eur J Heart Fail 18:1430\u20131441. https:\/\/doi.org\/10.1002\/ejhf.665","journal-title":"Eur J Heart Fail"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06424-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06424-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06424-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T16:03:36Z","timestamp":1760371416000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06424-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":23,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["6424"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06424-x","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"assertion":[{"value":"13 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Vall d\u2019Hebron Hospital Campus.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent for publication was obtained from the parents of each patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"623"}}